发明名称 Synthesis of 4-amino-thalidomide and its enantiomers that are suitable for inhibiting angiogenesis
摘要 A method of preparing S(-)-4-amino-thalidomide comprising: (a) contacting 3-nitrophthalic anhydride with S(-)-2-amino-glutarimide hydrobromide under conditions sufficient to form S(-)-4-nitro-thalidomide; and (b) reducing the S(-)-4-nitro-thalidomide under conditions sufficient to form S(-)-4-amino-thalidomide is disclosed; and similarly a method of preparing R(+)-4-amino-thalidomide comprising: (a) contacting 3-nitrophthalic anhydride with R(+)-2-amino-glutarimide hydrobromide under conditions sufficient to form R(+)-4-nitro-thalidomide; and (b) reducing the R(+)-4-nitro-thalidomide under conditions sufficient to form R(+)-4-amino-thalidomide is disclosed. These compounds are suitable for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration.
申请公布号 NZ526683(A) 申请公布日期 2008.03.28
申请号 NZ20010526683 申请日期 2001.11.30
申请人 THE CHILDREN'S MEDICAL CENTER CORPORATION 发明人 TRESTON, ANTHONY;SHAH, JAMSHED H;D'AMATO, ROBERT J;HUNSUCKER, KIMBERLY A;ROUGAS, JOHN;CONNER, BARRY P;PRIBLUDA, VICTOR;SWARTZ, GLENN M
分类号 C07D401/04;A61K31/454;A61P1/16;A61P1/18;A61P3/02;A61P3/10;A61P5/00;A61P7/00;A61P7/06;A61P9/00;A61P9/10;A61P13/08;A61P15/00;A61P17/00;A61P17/02;A61P17/06;A61P19/02;A61P19/04;A61P19/06;A61P25/00;A61P27/02;A61P27/06;A61P27/10;A61P29/00;A61P31/04;A61P31/10;A61P31/12;A61P31/22;A61P33/00;A61P35/00;A61P35/02;A61P35/04;A61P37/02;(IPC1-7):C07D401/04 主分类号 C07D401/04
代理机构 代理人
主权项
地址